tiprankstipranks
Trending News
More News >
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market

Sutro Biopharma (STRO) Financial Statements

Compare
719 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently $100.10M. The company's EPS TTM is $-6.7; its P/E ratio is -0.45; Sutro Biopharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-8.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 62.04M$ 153.73M$ 67.77M$ 61.88M$ 42.72M
Gross Profit$ 54.83M$ 146.91M$ 59.48M$ 52.11M$ -34.24M
Operating Income$ -238.45M$ -89.28M$ -128.94M$ -98.52M$ -71.06M
EBITDA$ -180.45M$ -67.92M$ -105.07M$ -97.56M$ -23.75M
Net Income$ -227.46M$ -106.79M$ -119.20M$ -105.54M$ -32.13M
Balance Sheet
Cash & Short-Term Investments$ 316.89M$ 375.62M$ 334.36M$ 197.94M$ 368.14M
Total Assets$ 387.21M$ 470.74M$ 406.94M$ 341.41M$ 394.11M
Total Debt$ 23.15M$ 33.63M$ 55.02M$ 57.37M$ 24.55M
Net Debt$ -167.15M$ -35.63M$ 7.76M$ 26.96M$ -181.61M
Total Liabilities$ 342.61M$ 321.09M$ 189.90M$ 88.84M$ 62.06M
Stockholders' Equity$ 44.60M$ 149.65M$ 217.05M$ 252.56M$ 332.05M
Cash Flow
Free Cash Flow$ -194.64M$ -115.93M$ -4.31M$ -97.00M$ -74.93M
Operating Cash Flow$ -191.54M$ -111.62M$ 3.55M$ -81.68M$ -67.80M
Investing Cash Flow$ 218.51M$ -3.92M$ -35.02M$ -97.31M$ 604.00K
Financing Cash Flow$ 94.05M$ 137.55M$ 48.31M$ 3.26M$ 269.25M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS